Five Prime Therapeutics (FPRX) Misses Q3 EPS by 30c
Tweet
Share
E-mailGet Alerts FPRX Hot Sheet
Join SI Premium – FREE
Five Prime Therapeutics (NASDAQ: FPRX) reported Q3 EPS of ($1.54), $0.30 worse than the analyst estimate of ($1.24).
For earnings history and earnings-related data on Five Prime Therapeutics (FPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Yum! Brands (YUM) PT Lowered to $180 at Argus
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
